Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	RAP1A TDRD9 ATP8A2 DNAH2 DNM1L MCM6 EIF2S3B ATP9A ATP10A KIF20B RAD50 EIF2S3 RECQL4 MCM9 CCT6B CCT8 MACF1 GNAL RASL10B DNAH8 MX1 DNM2	1.66e-07	775	156	22	GO:0017111
GeneOntologyMolecularFunction	ATP-dependent activity	MYO1C TDRD9 ATP8A2 DNAH2 MCM6 ATP9A ATP10A KIF20B ZRANB3 RAD50 ATP6V0D1 RECQL4 MCM9 SMARCA2 CCT6B CCT8 MACF1 DNAH8 ATP6V0A2	3.41e-07	614	156	19	GO:0140657
GeneOntologyMolecularFunction	pyrophosphatase activity	RAP1A TDRD9 ATP8A2 DNAH2 DNM1L MCM6 EIF2S3B ATP9A ATP10A KIF20B RAD50 EIF2S3 RECQL4 MCM9 CCT6B CCT8 MACF1 GNAL RASL10B DNAH8 MX1 DNM2	6.36e-07	839	156	22	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	RAP1A TDRD9 ATP8A2 DNAH2 DNM1L MCM6 EIF2S3B ATP9A ATP10A KIF20B RAD50 EIF2S3 RECQL4 MCM9 CCT6B CCT8 MACF1 GNAL RASL10B DNAH8 MX1 DNM2	6.49e-07	840	156	22	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	RAP1A TDRD9 ATP8A2 DNAH2 DNM1L MCM6 EIF2S3B ATP9A ATP10A KIF20B RAD50 EIF2S3 RECQL4 MCM9 CCT6B CCT8 MACF1 GNAL RASL10B DNAH8 MX1 DNM2	6.49e-07	840	156	22	GO:0016818
GeneOntologyMolecularFunction	ATP hydrolysis activity	TDRD9 ATP8A2 DNAH2 MCM6 ATP9A ATP10A KIF20B RAD50 RECQL4 MCM9 CCT6B CCT8 MACF1 DNAH8	9.82e-06	441	156	14	GO:0016887
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	RNMT RARS1 ERN1 TDRD9 POLE2 MCM6 ERVK-7 ZRANB3 RAD50 PNPT1 RECQL4 MCM9 SMARCA2 METTL2A METTL2B DNMT3A	4.69e-05	645	156	16	GO:0140640
GeneOntologyMolecularFunction	DNA helicase activity	MCM6 ZRANB3 RAD50 RECQL4 MCM9	1.23e-04	62	156	5	GO:0003678
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	POLE2 MCM6 ERVK-7 ZRANB3 RAD50 RECQL4 MCM9 SMARCA2 DNMT3A	2.24e-04	262	156	9	GO:0140097
GeneOntologyMolecularFunction	helicase activity	TDRD9 MCM6 ZRANB3 RAD50 RECQL4 MCM9 SMARCA2	2.47e-04	158	156	7	GO:0004386
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine phosphatase activity	PTPRA PTPRK PTPRO	2.93e-04	17	156	3	GO:0005001
GeneOntologyMolecularFunction	transmembrane receptor protein phosphatase activity	PTPRA PTPRK PTPRO	2.93e-04	17	156	3	GO:0019198
GeneOntologyMolecularFunction	tRNA (cytidine-3-)-methyltransferase activity	METTL2A METTL2B	3.60e-04	4	156	2	GO:0052735
GeneOntologyMolecularFunction	oxoglutarate dehydrogenase (succinyl-transferring) activity	OGDH OGDHL	3.60e-04	4	156	2	GO:0004591
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	RAP1A RAPGEF6 KALRN PLEKHG4 GCGR ARHGEF11 ARHGEF7 SBF2	4.75e-04	231	156	8	GO:0005085
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	MCM6 ZRANB3 RAD50 RECQL4 MCM9 SMARCA2	4.91e-04	127	156	6	GO:0008094
GeneOntologyMolecularFunction	insulin binding	IGF1R PIK3R1	5.97e-04	5	156	2	GO:0043559
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	IPO5 RAP1A RAPGEF6 KALRN PLEKHG4 ARHGAP10 DNM1L GCGR ARHGEF11 ARHGEF7 SBF2 ARHGAP29	6.50e-04	507	156	12	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	IPO5 RAP1A RAPGEF6 KALRN PLEKHG4 ARHGAP10 DNM1L GCGR ARHGEF11 ARHGEF7 SBF2 ARHGAP29	6.50e-04	507	156	12	GO:0030695
GeneOntologyMolecularFunction	peptide hormone binding	GCGR CRHR1 IGF1R PIK3R1	8.97e-04	55	156	4	GO:0017046
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	TLK2 ERN1 KALRN POLE2 ERVK-7 PI4KAP2 RET PARP14 MKNK1 FCSK PNPT1 IGF1R IKBKE PIK3R1 WEE2 ATM TAF1L	1.08e-03	938	156	17	GO:0016772
GeneOntologyMolecularFunction	hormone binding	GCGR CRHR1 IGF1R THRB PIK3R1	1.29e-03	103	156	5	GO:0042562
GeneOntologyMolecularFunction	ATPase-coupled intramembrane lipid transporter activity	ATP8A2 ATP9A ATP10A	1.33e-03	28	156	3	GO:0140326
GeneOntologyMolecularFunction	thiamine pyrophosphate binding	OGDH OGDHL	1.65e-03	8	156	2	GO:0030976
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor	OGDH OGDHL	2.11e-03	9	156	2	GO:0016624
GeneOntologyCellularComponent	microtubule	DPYSL2 RIBC2 DNAH2 DNM1L KIF20B SLC8A2 TRIM63 CCT8 MACF1 CLMP DNAH8 MX1 DNM2 CHMP1A	3.88e-05	533	153	14	GO:0005874
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	RAP1A GGA2 MYO1C ARHGAP10 VPS45 ATP8A2 DNM1L RET CUBN ATP9A LIN7A ZFYVE28 CD4 ATP6V0D1 SBF2 VPS41 ATM NOSTRIN ECE2 ATP6V0A2 CLBA1 DNM2 CHMP1A	7.96e-05	1307	153	23	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	RAP1A GGA2 MYO1C ARHGAP10 VPS45 ATP8A2 DNM1L RET CUBN ATP9A LIN7A ZFYVE28 CD4 ATP6V0D1 SBF2 VPS41 ATM NOSTRIN ECE2 ATP6V0A2 CLBA1 DNM2 CHMP1A	9.77e-05	1325	153	23	GO:0012506
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	TLK2 DPYSL2 MYO1C RIBC2 DNAH2 DNM1L POTEKP CORO1B KIF20B SLC8A2 TRIM63 CCT8 MACF1 CLMP DNAH8 MX1 DNM2 CHMP1A	1.05e-04	899	153	18	GO:0099513
GeneOntologyCellularComponent	endosome	RAP1A GGA2 ARHGAP10 VPS45 ATP8A2 VPS8 GCGR RET CUBN ATP9A ACKR4 CRHR1 ZFYVE28 CD4 ATP6V0D1 AP5Z1 SBF2 VPS41 ATP6V0A2 DNM2 CHMP1A	1.23e-04	1167	153	21	GO:0005768
GeneOntologyCellularComponent	endosome membrane	RAP1A GGA2 ARHGAP10 VPS45 ATP8A2 RET ATP9A ZFYVE28 ATP6V0D1 SBF2 VPS41 ATP6V0A2 CHMP1A	4.97e-04	602	153	13	GO:0010008
Domain	Dynamin_central	DNM1L MX1 DNM2	9.98e-06	6	150	3	IPR000375
Domain	GED	DNM1L MX1 DNM2	9.98e-06	6	150	3	SM00302
Domain	Dynamin_M	DNM1L MX1 DNM2	9.98e-06	6	150	3	PF01031
Domain	GED_dom	DNM1L MX1 DNM2	9.98e-06	6	150	3	IPR020850
Domain	GED	DNM1L MX1 DNM2	9.98e-06	6	150	3	PS51388
Domain	Dynamin_GTPase_CS	DNM1L MX1 DNM2	9.98e-06	6	150	3	IPR019762
Domain	GED	DNM1L MX1 DNM2	9.98e-06	6	150	3	PF02212
Domain	GED	DNM1L MX1 DNM2	9.98e-06	6	150	3	IPR003130
Domain	P-loop_NTPase	RAP1A SAMD9 MYO1C TDRD9 DNAH2 DNM1L MCM6 KIF20B ZRANB3 RAD50 TJP1 EIF2S3 RECQL4 MCM9 SMARCA2 GNAL RASL10B DNAH8 MX1 DNM2	1.52e-05	848	150	20	IPR027417
Domain	G_DYNAMIN_1	DNM1L MX1 DNM2	1.74e-05	7	150	3	PS00410
Domain	DYNc	DNM1L MX1 DNM2	1.74e-05	7	150	3	SM00053
Domain	-	RAP1A SAMD9 TDRD9 DNAH2 DNM1L MCM6 ZRANB3 RAD50 TJP1 EIF2S3 RECQL4 MCM9 SMARCA2 GNAL RASL10B DNAH8 MX1 DNM2	3.11e-05	746	150	18	3.40.50.300
Domain	2-oxogl_dehyd_N	OGDH OGDHL	6.41e-05	2	150	2	IPR032106
Domain	2-oxogl_dehyd_N	OGDH OGDHL	6.41e-05	2	150	2	PF16078
Domain	G_DYNAMIN_dom	DNM1L MX1 DNM2	1.73e-04	14	150	3	IPR030381
Domain	P_typ_ATPase_c	ATP8A2 ATP9A ATP10A	1.73e-04	14	150	3	IPR032630
Domain	P-type_ATPase_N	ATP8A2 ATP9A ATP10A	1.73e-04	14	150	3	IPR032631
Domain	P-type_ATPase_IV	ATP8A2 ATP9A ATP10A	1.73e-04	14	150	3	IPR006539
Domain	PhoLip_ATPase_C	ATP8A2 ATP9A ATP10A	1.73e-04	14	150	3	PF16212
Domain	PhoLip_ATPase_N	ATP8A2 ATP9A ATP10A	1.73e-04	14	150	3	PF16209
Domain	G_DYNAMIN_2	DNM1L MX1 DNM2	1.73e-04	14	150	3	PS51718
Domain	2oxoglutarate_DH_E1	OGDH OGDHL	1.91e-04	3	150	2	IPR011603
Domain	KGD_C	OGDH OGDHL	1.91e-04	3	150	2	IPR031717
Domain	OxoGdeHyase_C	OGDH OGDHL	1.91e-04	3	150	2	PF16870
Domain	BROMODOMAIN_1	TRIM33 PBRM1 SMARCA2 TAF1L	2.15e-04	37	150	4	PS00633
Domain	Dynamin_GTPase	DNM1L MX1 DNM2	2.15e-04	15	150	3	IPR001401
Domain	Dynamin_SF	DNM1L MX1 DNM2	2.15e-04	15	150	3	IPR022812
Domain	Dynamin_N	DNM1L MX1 DNM2	2.15e-04	15	150	3	PF00350
Domain	Bromodomain	TRIM33 PBRM1 SMARCA2 TAF1L	2.39e-04	38	150	4	PF00439
Domain	BROMODOMAIN_2	TRIM33 PBRM1 SMARCA2 TAF1L	3.21e-04	41	150	4	PS50014
Domain	Bromodomain	TRIM33 PBRM1 SMARCA2 TAF1L	3.53e-04	42	150	4	IPR001487
Domain	BROMO	TRIM33 PBRM1 SMARCA2 TAF1L	3.53e-04	42	150	4	SM00297
Domain	-	TRIM33 PBRM1 SMARCA2 TAF1L	3.53e-04	42	150	4	1.20.920.10
Domain	SH3	KALRN ARHGAP10 SPTA1 TJP1 ARHGEF7 PIK3R1 MACF1 NOSTRIN	3.63e-04	216	150	8	PS50002
Domain	MeTrfase	METTL2A METTL2B	3.80e-04	4	150	2	IPR026113
Domain	SH3_domain	KALRN ARHGAP10 SPTA1 TJP1 ARHGEF7 PIK3R1 MACF1 NOSTRIN	4.10e-04	220	150	8	IPR001452
Domain	Spectrin	KALRN SPTA1 MACF1	7.99e-04	23	150	3	PF00435
Domain	ZF_BED	ZBED5 ZBED6	9.41e-04	6	150	2	PS50808
Domain	PQQ	ERN1 ZNF106	9.41e-04	6	150	2	SM00564
Domain	zf-BED	ZBED5 ZBED6	9.41e-04	6	150	2	PF02892
Domain	E1_dh	OGDH OGDHL	9.41e-04	6	150	2	PF00676
Domain	PQQ_repeat	ERN1 ZNF106	9.41e-04	6	150	2	IPR002372
Domain	DH_E1	OGDH OGDHL	9.41e-04	6	150	2	IPR001017
Domain	Methyltransf_12	METTL2A METTL2B	9.41e-04	6	150	2	IPR013217
Domain	Methyltransf_12	METTL2A METTL2B	9.41e-04	6	150	2	PF08242
Domain	PQQ_beta_propeller_repeat	ERN1 ZNF106	9.41e-04	6	150	2	IPR018391
Domain	Bromodomain_CS	PBRM1 SMARCA2 TAF1L	1.15e-03	26	150	3	IPR018359
Domain	ZnF_UBR1	UBR2 UBR7	1.31e-03	7	150	2	SM00396
Domain	ZF_UBR	UBR2 UBR7	1.31e-03	7	150	2	PS51157
Domain	zf-UBR	UBR2 UBR7	1.31e-03	7	150	2	PF02207
Domain	Znf_UBR	UBR2 UBR7	1.31e-03	7	150	2	IPR003126
Domain	Spectrin_repeat	KALRN SPTA1 MACF1	1.59e-03	29	150	3	IPR002017
Domain	DH_1	KALRN PLEKHG4 ARHGEF11 ARHGEF7	1.65e-03	63	150	4	PS00741
Domain	DHC_N1	DNAH2 DNAH8	1.74e-03	8	150	2	PF08385
Domain	Transketolase-like_Pyr-bd	OGDH OGDHL	1.74e-03	8	150	2	IPR005475
Domain	MCM_OB	MCM6 MCM9	1.74e-03	8	150	2	PF17207
Domain	Transket_pyr	OGDH OGDHL	1.74e-03	8	150	2	SM00861
Domain	Transket_pyr	OGDH OGDHL	1.74e-03	8	150	2	PF02779
Domain	MCM_OB	MCM6 MCM9	1.74e-03	8	150	2	IPR033762
Domain	MCM_2	MCM6 MCM9	1.74e-03	8	150	2	PS50051
Domain	MCM_1	MCM6 MCM9	1.74e-03	8	150	2	PS00847
Domain	Dynein_heavy_dom-1	DNAH2 DNAH8	1.74e-03	8	150	2	IPR013594
Domain	SH3	KALRN ARHGAP10 SPTA1 TJP1 ARHGEF7 PIK3R1 NOSTRIN	1.83e-03	216	150	7	SM00326
Domain	-	ATP8A2 ATP9A ATP10A	2.12e-03	32	150	3	3.40.1110.10
Domain	-	ATP8A2 ATP9A ATP10A	2.12e-03	32	150	3	2.70.150.10
Domain	SPEC	KALRN SPTA1 MACF1	2.12e-03	32	150	3	SM00150
Domain	Spectrin/alpha-actinin	KALRN SPTA1 MACF1	2.12e-03	32	150	3	IPR018159
Domain	RhoGEF	KALRN PLEKHG4 ARHGEF11 ARHGEF7	2.18e-03	68	150	4	SM00325
Domain	MCM	MCM6 MCM9	2.22e-03	9	150	2	SM00350
Domain	MCM_dom	MCM6 MCM9	2.22e-03	9	150	2	IPR001208
Domain	Chaperonin_TCP-1_CS	CCT6B CCT8	2.22e-03	9	150	2	IPR002194
Domain	MCM	MCM6 MCM9	2.22e-03	9	150	2	IPR031327
Domain	MCM	MCM6 MCM9	2.22e-03	9	150	2	PF00493
Domain	RhoGEF	KALRN PLEKHG4 ARHGEF11 ARHGEF7	2.43e-03	70	150	4	PF00621
Domain	DH_2	KALRN PLEKHG4 ARHGEF11 ARHGEF7	2.43e-03	70	150	4	PS50010
Domain	-	KALRN PLEKHG4 ARHGEF11 ARHGEF7	2.56e-03	71	150	4	1.20.900.10
Domain	DH-domain	KALRN PLEKHG4 ARHGEF11 ARHGEF7	2.56e-03	71	150	4	IPR000219
Domain	ATPase_P-typ_cyto_domN	ATP8A2 ATP9A ATP10A	2.75e-03	35	150	3	IPR023299
Domain	TCP1_1	CCT6B CCT8	2.76e-03	10	150	2	PS00750
Domain	TCP1_2	CCT6B CCT8	2.76e-03	10	150	2	PS00751
Domain	TCP1_3	CCT6B CCT8	2.76e-03	10	150	2	PS00995
Domain	Chaperone_TCP-1	CCT6B CCT8	2.76e-03	10	150	2	IPR017998
Domain	-	RNMT METTL2A ECE2 METTL2B DNMT3A	2.84e-03	120	150	5	3.40.50.150
Domain	ATPase_P-typ_P_site	ATP8A2 ATP9A ATP10A	2.99e-03	36	150	3	IPR018303
Domain	PTPc	PTPRA PTPRK PTPRO	2.99e-03	36	150	3	SM00194
Domain	P_typ_ATPase	ATP8A2 ATP9A ATP10A	2.99e-03	36	150	3	IPR001757
Domain	ATPASE_E1_E2	ATP8A2 ATP9A ATP10A	2.99e-03	36	150	3	PS00154
Domain	SAM-dependent_MTases	RNMT METTL2A ECE2 METTL2B DNMT3A	3.05e-03	122	150	5	IPR029063
Domain	ATPase_P-typ_transduc_dom_A	ATP8A2 ATP9A ATP10A	3.23e-03	37	150	3	IPR008250
Domain	E1-E2_ATPase	ATP8A2 ATP9A ATP10A	3.23e-03	37	150	3	PF00122
Domain	-	CCT6B CCT8	3.36e-03	11	150	2	3.30.260.10
Domain	TCP-1-like_intermed	CCT6B CCT8	3.36e-03	11	150	2	IPR027410
Domain	GDS_CDC24_CS	PLEKHG4 ARHGEF11 ARHGEF7	3.75e-03	39	150	3	IPR001331
Domain	TYR_PHOSPHATASE_PTP	PTPRA PTPRK PTPRO	3.75e-03	39	150	3	PS50055
Domain	Znf_BED	ZBED5 ZBED6	4.01e-03	12	150	2	IPR003656
Domain	PTPase_domain	PTPRA PTPRK PTPRO	4.33e-03	41	150	3	IPR000242
Domain	Y_phosphatase	PTPRA PTPRK PTPRO	4.33e-03	41	150	3	PF00102
Domain	Kinase-like_dom	TLK2 ERN1 KALRN RET MKNK1 IGF1R IKBKE MACF1 WEE2 ATM DNM2	4.40e-03	542	150	11	IPR011009
Domain	THDP-binding	OGDH OGDHL	4.72e-03	13	150	2	IPR029061
Domain	-	OGDH OGDHL	4.72e-03	13	150	2	3.40.50.970
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	SEMA4D DPYSL2 KALRN SPTA1 RET ARHGEF11 PTPRA ARHGEF7 PLXNC1 PIK3R1 DNM2	2.04e-05	261	125	11	MM15676
Pathway	BIOCARTA_IGF1MTOR_PATHWAY	EIF2S3B IGF1R PIK3R1 EIF2S3	2.56e-05	20	125	4	MM1496
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DPYSL2 GGA2 ACACA VPS45 CNTRL CASP8 CORO1B ARHGEF11 CARD8 RAD50 TJP1 NFKB1 ARHGAP29 CCT6B CCT8 TAF2 ZNF565 PCID2 WDR62	1.21e-08	853	157	19	28718761
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	IPO5 CUL2 DPYSL2 MYO1C SPTLC2 PSMD1 MCM6 NR2F2 RAD50 TRIM33 PPP2R5A ATP6V0D1 AP5Z1 PCID2 DNM2	4.30e-08	560	157	15	35241646
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	UBR2 SEMA4D RNF130 DPYSL2 RAP1A ACACA ARHGAP10 VPS45 PSMD1 PPHLN1 SMOC2 OGDH ATP10A PPP4R4 IGF1R THRB GUCY1A1 TJP1 SBF2 VPS41 SMARCA2 MACF1 CLBA1	2.63e-07	1489	157	23	28611215
Pubmed	Viral Infection-Induced Differential Expression of LncRNAs Associated with Collagen in Mouse Placentas and Amniotic Sacs.	ARHGAP10 ATP8A2 PSMD1 ADAMTS13 ATP9A ZRANB3 YJU2B	3.76e-07	100	157	7	26073538
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	IPO5 CUL2 DPYSL2 ARHGAP10 SPTLC2 POLE2 PSMD1 DNM1L MCM6 EIF2S3B LIN7A RAD50 PTPRA PTPRK PTPRO TJP1 CCT6B CCT8	4.74e-07	974	157	18	28675297
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IPO5 DPYSL2 MYO1C KALRN VPS45 SPTA1 DNM1L EIF2S3B CORO1B ATP9A ARHGEF11 OGDH JMY SLC8A2 ATP6V0D1 PTPRA TJP1 EIF2S3 CCT8 OGDHL MACF1 DNM2	5.34e-07	1431	157	22	37142655
Pubmed	ATM activation is impaired in human cells defective in RecQL4 helicase activity.	RAD50 RECQL4 ATM	8.97e-07	5	157	3	30594395
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	IPO5 CUL2 DPYSL2 SPTA1 EIF2S3B OGDH IGF1R ATP6V0D1 EIF2S3 CCT6B CCT8 GNAL ATP6V0A2 DNM2	9.74e-07	621	157	14	22794259
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	IPO5 SEMA4D DPYSL2 KALRN VPS45 PSMD1 ZBED5 TRIM33 PTPRA PTPRK ADAMTS9 TJP1 PIK3R1 MACF1 C1S ATM ZNF565 COG4 ECE2 DNM2	1.53e-06	1285	157	20	35914814
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IPO5 DPYSL2 ACACA MYO1C PSMD1 MCM6 RAD50 PNPT1 PBRM1 TJP1 SMARCA2 MACF1 ATM DNM2	1.75e-06	653	157	14	22586326
Pubmed	NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinases.	CD4 IKBKE NFKB1	1.79e-06	6	157	3	11959143
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	REC8 IPO5 TLK2 RNF130 ZSWIM3 ACACA SPTLC2 DNM1L MCM6 PPHLN1 PPP4R4 SCRN2 ZNF106 PBRM1 PTPRA THRB ARHGEF7 MCM9 VPS41 ATP6V0A2	2.48e-06	1327	157	20	32694731
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DPYSL2 RARS1 ACACA MYO1C PLEKHG4 SPTLC2 CASP8 PSMD1 MCM6 CORO1B KIF20B ZBED5 RAD50 RECQL4 SMARCA2 CCT6B CCT8 MACF1 TAF2 PCID2	3.32e-06	1353	157	20	29467282
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	RARS1 ACACA MYO1C SPTA1 PTPRA PIK3R1 CCT6B CCT8 DNM2	3.69e-06	266	157	9	19380743
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	IPO5 DPYSL2 RNMT PSMD1 MCM6 CORO1B ARHGEF11 OGDH CCT8 DNM2	4.07e-06	344	157	10	30333137
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	RAP1A RARS1 ARHGAP10 VPS45 PPHLN1 ATP9A ARHGEF11 KIF20B TRIM33 PBRM1 ATP6V0D1 ZBED6 EIF2S3 SMARCA2 CCT8 MACF1 ATF1 TAF2 TAF1L PCID2 ATP6V0A2	4.17e-06	1497	157	21	31527615
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	TLK2 CUL2 SEMA4D ATP8A2 DNAH2 DNM1L IGF1R PTPRA SMARCA2 METTL2A TAF1L METTL2B ATP6V0A2 DNM2	6.29e-06	730	157	14	34857952
Pubmed	A protein interaction landscape of breast cancer.	IPO5 CUL2 UBR2 SPTLC2 CASP8 OGDH ZNF106 ATP6V0D1 PIK3R1 MCM9 SMARCA2 MACF1 DNM2	6.72e-06	634	157	13	34591612
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	IPO5 CUL2 DPYSL2 RAP1A RARS1 ACACA MYO1C DNM1L CORO1B GPR180 ZNF106 ATP6V0D1 TJP1 EIF2S3 CCT8 MACF1 PCID2 DNM2 CHMP1A	6.77e-06	1297	157	19	33545068
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TLK2 DPYSL2 RAP1A KALRN TRPC4 DNM1L CORO1B ARHGEF11 RAD50 CNTNAP5 PBRM1 TJP1 ARHGEF7 CCT8 MACF1 DNM2	8.18e-06	963	157	16	28671696
Pubmed	The type 4 subfamily of P-type ATPases, putative aminophospholipid translocases with a role in human disease.	ATP8A2 ATP9A ATP10A	1.06e-05	10	157	3	15919184
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	DPYSL2 RAP1A KALRN SPTA1 DNM1L PPP4R4 FCSK SMARCA2 COG4	1.08e-05	304	157	9	32235678
Pubmed	Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.	IPO5 RAD50 ATM	1.45e-05	11	157	3	15758953
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	IPO5 UBR2 RARS1 ACACA MYO1C GSKIP PSMD1 MCM6 CORO1B PNPT1 IGF1R TJP1 PIK3R1 EIF2S3 SMARCA2 CCT8 PCID2 DNM2	1.47e-05	1247	157	18	27684187
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	IPO5 CUL2 DPYSL2 RNMT DNM1L MCM6 PPHLN1 NR2F2 RAD50 TRIM33 PBRM1 SMARCA2 CCT8 ATF1 ATM TAF2	1.54e-05	1014	157	16	32416067
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	CASP8 IGF1R PBRM1 PIK3R1 ATM	1.80e-05	71	157	5	28319113
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	ACACA PPHLN1 KIF20B MKNK1 RAD50 TRIM33 EIF2S3 SMARCA2 DNMT3A CHMP1A	1.91e-05	411	157	10	35182466
Pubmed	Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.	IKBKE NFKB1	2.02e-05	2	157	2	16299251
Pubmed	A rapid cytoplasmic mechanism for PI3 kinase regulation by the nuclear thyroid hormone receptor, TRβ, and genetic evidence for its role in the maturation of mouse hippocampal synapses in vivo.	THRB PIK3R1	2.02e-05	2	157	2	24932806
Pubmed	Transduction of activation signal that follows HIV-1 binding to CD4 and CD4 dimerization involves the immunoglobulin CDR3-like region in domain 1 of CD4.	CD4 NFKB1	2.02e-05	2	157	2	9235945
Pubmed	Canonical transient receptor potential channel 4 (TRPC4) co-localizes with the scaffolding protein ZO-1 in human fetal astrocytes in culture.	TRPC4 TJP1	2.02e-05	2	157	2	15540229
Pubmed	Loss of caspase-8 in hepatocytes accelerates the onset of liver regeneration in mice through premature nuclear factor kappa B activation.	CASP8 NFKB1	2.02e-05	2	157	2	23728913
Pubmed	PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.	PBRM1 NFKB1	2.02e-05	2	157	2	37095322
Pubmed	Rho GTP exchange factor ARHGEF11 regulates the integrity of epithelial junctions by connecting ZO-1 and RhoA-myosin II signaling.	ARHGEF11 TJP1	2.02e-05	2	157	2	22665792
Pubmed	IGF-I: a mitogen also involved in differentiation processes in mammalian cells.	IGF1R PIK3R1	2.02e-05	2	157	2	8697095
Pubmed	Dymple, a novel dynamin-like high molecular weight GTPase lacking a proline-rich carboxyl-terminal domain in mammalian cells.	DNM1L MX1	2.02e-05	2	157	2	9422767
Pubmed	Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression.	NFKB1 ATM	2.02e-05	2	157	2	22096476
Pubmed	Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.	CD4 DNM2	2.02e-05	2	157	2	18715908
Pubmed	NF-κB1/IKKε Gene Expression and Clinical Activity in Patients With Rheumatoid Arthritis.	IKBKE NFKB1	2.02e-05	2	157	2	29069487
Pubmed	[Not Available].	RET NFKB1	2.02e-05	2	157	2	30484597
Pubmed	Regulation of large conductance Ca2+-activated K+ (BK) channel β1 subunit expression by muscle RING finger protein 1 in diabetic vessels.	KCNMB1 TRIM63	2.02e-05	2	157	2	24570002
Pubmed	Advanced glycation end products promote human aortic smooth muscle cell calcification in vitro via activating NF-κB and down-regulating IGF1R expression.	IGF1R NFKB1	2.02e-05	2	157	2	23416929
Pubmed	COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells.	NR2F2 NFKB1	2.02e-05	2	157	2	24141032
Pubmed	Beta-Pix-dynamin 2 complex promotes colorectal cancer progression by facilitating membrane dynamics.	ARHGEF7 DNM2	2.02e-05	2	157	2	34582006
Pubmed	Involvement of NF-κB and muscle specific E3 ubiquitin ligase MuRF1 in cigarette smoke-induced catabolism in C2 myotubes.	NFKB1 TRIM63	2.02e-05	2	157	2	23835952
Pubmed	HIV-1 reactivation in resting peripheral blood mononuclear cells of infected adults upon in vitro CD4 cross-linking by ligands of the CDR2-loop in extracellular domain 1.	CD4 NFKB1	2.02e-05	2	157	2	10235509
Pubmed	IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation.	IKBKE NFKB1	2.02e-05	2	157	2	16840782
Pubmed	Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1.	IGF1R ATM	2.02e-05	2	157	2	15345673
Pubmed	Resveratrol attenuates skeletal muscle atrophy induced by chronic kidney disease via MuRF1 signaling pathway.	NFKB1 TRIM63	2.02e-05	2	157	2	28392400
Pubmed	Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway.	RET PIK3R1	2.02e-05	2	157	2	10652352
Pubmed	Cancer-associated missense mutations of caspase-8 activate nuclear factor-κB signaling.	CASP8 NFKB1	2.02e-05	2	157	2	23659359
Pubmed	Contact-induced mitochondrial polarization supports HIV-1 virological synapse formation.	DNM1L CD4	2.02e-05	2	157	2	25320323
Pubmed	Invasive skin carcinoma--Ras and alpha6beta4 integrin lead the way.	IKBKE NFKB1	2.02e-05	2	157	2	12676577
Pubmed	Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain.	EIF2S3B EIF2S3	2.02e-05	2	157	2	16325480
Pubmed	Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system.	IGF1R PIK3R1	2.02e-05	2	157	2	7589433
Pubmed	Differential expression of putative transbilayer amphipath transporters.	ATP8A2 ATP9A ATP10A	2.50e-05	13	157	3	11015572
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	DPYSL2 MYO1C PSMD1 IGF1R TJP1 CCT8 MACF1	2.75e-05	191	157	7	33762435
Pubmed	A network of chaperones prevents and detects failures in membrane protein lipid bilayer integration.	CORO1B OGDH OGDHL	3.95e-05	15	157	3	30737405
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	MYO1C EIF2S3B OGDH PNPT1 ZNF106 EIF2S3 CCT8	4.05e-05	203	157	7	35012549
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MYO1C RIBC2 ARHGAP10 RAD50 TRIM33 FCSK PPP2R5A PBRM1 PIK3R1 SMARCA2 MACF1 CLMP TAF2 PCID2 WDR62 TCTN2	4.87e-05	1116	157	16	31753913
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	GGA2 ACACA MYO1C CCDC146 VPS45 CNTRL DNM1L TRIM33 TJP1 ZBED6 EIF2S3 CCT8 ATP6V0A2	5.57e-05	777	157	13	35844135
Pubmed	Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.	IGF1R PIK3R1	6.06e-05	3	157	2	12220227
Pubmed	The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.	RET TRIM33	6.06e-05	3	157	2	10439047
Pubmed	ATM-dependent phosphorylation of nibrin in response to radiation exposure.	RAD50 ATM	6.06e-05	3	157	2	10802669
Pubmed	MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.	CASP8 PIK3R1	6.06e-05	3	157	2	26988918
Pubmed	DNMT3A-mediated silence in ADAMTS9 expression is restored by RNF180 to inhibit viability and motility in gastric cancer cells.	ADAMTS9 DNMT3A	6.06e-05	3	157	2	33931579
Pubmed	ER stress activates NF-κB by integrating functions of basal IKK activity, IRE1 and PERK.	ERN1 NFKB1	6.06e-05	3	157	2	23110043
Pubmed	Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression.	CCNG1 PIK3R1	6.06e-05	3	157	2	22271581
Pubmed	IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin.	IGF1R ATM	6.06e-05	3	157	2	27472395
Pubmed	PARP14 correlates with GBM proliferation and poor prognosis by elevating expression of SAMD/SAMD9L.	SAMD9 PARP14	6.06e-05	3	157	2	37612499
Pubmed	Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.	PBRM1 SMARCA2	6.06e-05	3	157	2	25496315
Pubmed	NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.	PIK3R1 NFKB1	6.06e-05	3	157	2	20433747
Pubmed	The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis.	DNM1L DNM2	6.06e-05	3	157	2	32573516
Pubmed	An RPTPα/Src family kinase/Rap1 signaling module recruits myosin IIB to support contractile tension at apical E-cadherin junctions.	RAP1A PTPRA	6.06e-05	3	157	2	25631816
Pubmed	Rap1A accelerates homocysteine-induced ANA-1 cells inflammation via synergy of FoxO1 and DNMT3a.	RAP1A DNMT3A	6.06e-05	3	157	2	36791985
Pubmed	RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway.	UBR2 RECQL4	6.06e-05	3	157	2	15317757
Pubmed	TRAF6 regulates cell fate decisions by inducing caspase 8-dependent apoptosis and the activation of NF-kappaB.	CASP8 NFKB1	6.06e-05	3	157	2	16436380
Pubmed	The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8.	CASP8 TNFRSF21	6.06e-05	3	157	2	34012073
Pubmed	Mechanisms underlying mouse TNF-α stimulated neutrophil derived microparticle generation.	CASP8 NFKB1	6.06e-05	3	157	2	23850678
Pubmed	The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4.	CD4 NFKB1	6.06e-05	3	157	2	9621091
Pubmed	Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling.	THRB PIK3R1	6.06e-05	3	157	2	17606624
Pubmed	Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.	PTPRO NFKB1	6.06e-05	3	157	2	25034527
Pubmed	Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.	RAD50 ATM	6.06e-05	3	157	2	10839544
Pubmed	Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail.	IGF1R NFKB1	6.06e-05	3	157	2	17296734
Pubmed	AMPK regulates ER morphology and function in stressed pancreatic β-cells via phosphorylation of DRP1.	ERN1 DNM1L	6.06e-05	3	157	2	23979843
Pubmed	MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-κB Pathway.	IKBKE NFKB1	6.06e-05	3	157	2	29333957
Pubmed	Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxia‑telangiectasia mutated and nuclear factor‑κB pathways in gastric cancer cells.	NFKB1 ATM	6.06e-05	3	157	2	30106453
Pubmed	S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-κB.	CASP8 NFKB1	6.06e-05	3	157	2	24762656
Pubmed	Fine mapping of the 9q31 Hirschsprung's disease locus.	RET SVEP1	6.06e-05	3	157	2	20361209
Pubmed	Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage.	NFKB1 ATM	6.06e-05	3	157	2	15044535
Pubmed	Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury.	IGF1R PTPRA	6.06e-05	3	157	2	17500057
Pubmed	Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol.	CASP8 DNM1L	6.06e-05	3	157	2	12668660
Pubmed	Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma.	PIK3R1 NFKB1	6.06e-05	3	157	2	23603894
Pubmed	Recruitment and activation of the ATM kinase in the absence of DNA-damage sensors.	RAD50 ATM	6.06e-05	3	157	2	26280532
Pubmed	Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages.	CD4 NFKB1	6.06e-05	3	157	2	21637819
Pubmed	miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM.	ATF1 ATM	6.06e-05	3	157	2	28259977
Pubmed	Rap1 Spatially Controls ArhGAP29 To Inhibit Rho Signaling during Endothelial Barrier Regulation.	RAP1A ARHGAP29	6.06e-05	3	157	2	25963656
Pubmed	Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants.	PIK3R1 NFKB1	6.06e-05	3	157	2	34922003
Pubmed	ATM kinase promotes both caspase-8 and caspase-9 activation during TNF-α-induced apoptosis of HeLa cells.	CASP8 ATM	6.06e-05	3	157	2	24530529
Pubmed	ATM protein-dependent phosphorylation of Rad50 protein regulates DNA repair and cell cycle control.	RAD50 ATM	6.06e-05	3	157	2	21757780
Interaction	EED interactions	IPO5 CUL2 RARS1 ACACA MYO1C VPS45 PSMD1 DNM1L MCM6 PPHLN1 CORO1B CUBN KIF20B RAD50 IGF1R PBRM1 ATP6V0D1 TJP1 EIF2S3 VPS41 SMARCA2 TRIM63 CCT8 MACF1 MDGA1 DNM2 DNMT3A CHMP1A	4.99e-06	1445	155	28	int:EED
Interaction	CBL interactions	IPO5 UBR2 DPYSL2 ACACA MYO1C VPS45 SPTA1 RET CUBN IGF1R ARHGEF7 PIK3R1 CCT8 GNAL ATM	1.11e-05	516	155	15	int:CBL
Interaction	IMPDH2 interactions	IPO5 CUL2 MYO1C PSMD1 DNM1L JMY RAD50 IKBKE EIF2S3 NFKB1 RECQL4 CCT8 PCID2	2.28e-05	420	155	13	int:IMPDH2
Interaction	C9orf78 interactions	IPO5 CUL2 DPYSL2 MYO1C SPTLC2 PSMD1 MCM6 UBR7 NR2F2 RAD50 TRIM33 PPP2R5A ATP6V0D1 AP5Z1 PCID2 DNM2	2.42e-05	620	155	16	int:C9orf78
Interaction	HOOK3 interactions	ACACA VPS45 CORO1B ARHGEF11 RAD50 TJP1 NFKB1 VPS41 WDR62	2.72e-05	202	155	9	int:HOOK3
Interaction	GSK3B interactions	IPO5 DPYSL2 RAPGEF6 SAMD9 RARS1 ACACA MYO1C GSKIP PSMD1 DNM1L MCM6 ARHGEF11 TJP1 NFKB1 RECQL4 ARHGAP29 CCT8 MACF1 WDR62	3.95e-05	868	155	19	int:GSK3B
Cytoband	7p14-p13	OGDH VPS41	6.94e-05	4	157	2	7p14-p13
GeneFamily	ATPase phospholipid transporting	ATP8A2 ATP9A ATP10A	9.20e-05	15	109	3	1210
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRA PTPRK PTPRO	2.62e-04	21	109	3	813
GeneFamily	Zinc fingers BED-type\|Pseudoautosomal region 1	ZBED5 ZBED6	5.32e-04	6	109	2	64
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	KALRN PLEKHG4 ARHGEF11 ARHGEF7	6.76e-04	66	109	4	722
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR2 UBR7	7.42e-04	7	109	2	785
GeneFamily	MCM family	MCM6 MCM9	1.26e-03	9	109	2	1085
GeneFamily	Chaperonins	CCT6B CCT8	3.59e-03	15	109	2	587
Coexpression	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	SEMA4D SAMD9 CASP8 PARP14 ATP10A GPR180 PNPT1 IKBKE MX1	2.70e-06	195	156	9	M4292
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN	TLK2 SEMA4D SAMD9 PARP14 ARHGEF11 GPR180 PNPT1 IKBKE MX1	2.82e-06	196	156	9	M4267
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	IPO5 UBR2 RNF130 DPYSL2 ACACA VPS45 CNTRL RET ATP10A UBR7 CARD8 CCNG1 RNF14 TRIM33 ZNF106 ARHGEF7 PLXNC1 VPS41 MACF1 ATF1 GNAL ATM	3.29e-06	1215	156	22	M41122
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	UBR2 TDRD9 PARP14 IGF1R CD4 PTPRA VPS41 MACF1	5.72e-06	161	156	8	M9446
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	IPO5 CUL2 RAPGEF6 RNMT ARHGAP10 DNM1L KIF20B RAD50 TRIM33 PBRM1 PLXNC1 VPS41 SMARCA2 TRIM63 ATM	9.38e-06	656	156	15	M18979
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE	UBR2 DPYSL2 PILRA SPTLC2 CORO1B OGDH CARD8 CD4 ATP6V0D1 PLXNC1 KCNMB1 PCID2	9.96e-06	426	156	12	M41019
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TLK2 CUL2 UBR2 RAP1A CASP8 KIF20B NR2F2 TRIM33 PPP2R5A IGF1R PTPRA PTPRK ARHGEF7 NFKB1 SMARCA2 ARHGAP29 MACF1	1.46e-05	856	156	17	M4500
Coexpression	HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP	SAMD9 CCDC146 PILRA SPTA1 RET PARP14 ARHGEF11 ATP10A GPR180 PNPT1 GUCY1A1 TJP1 KCNMB1 C1S CLMP MDGA1 DNAH8 MX1	2.09e-05	973	156	18	M41080
Coexpression	GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP	ACACA CNTRL VPS8 TRIM33 PTPRK ARHGEF7 NFKB1 MACF1	2.39e-05	196	156	8	M3243
Coexpression	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN	TLK2 SAMD9 PARP14 ARHGEF11 ATP10A GPR180 PNPT1 MX1	2.48e-05	197	156	8	M4294
Coexpression	HALLMARK_INTERFERON_ALPHA_RESPONSE	SAMD9 CASP8 PARP14 PNPT1 C1S MX1	2.55e-05	97	156	6	M5911
Coexpression	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	REC8 SAMD9 SPTLC2 PARP14 ATP10A PNPT1 PLXNC1 MX1	2.76e-05	200	156	8	M3288
Coexpression	GSE22886_NAIVE_BCELL_VS_DC_DN	RARS1 PILRA PSMD1 DNM1L MKNK1 RAD50 RNF14 ZNF106	2.76e-05	200	156	8	M4484
Coexpression	DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP	IPO5 SEMA4D RNF130 RAP1A POLE2 SPTA1 CASP8 PSMD1 DNM1L OGDH RAD50 CCNG1 RNF14 PPP2R5A PTPRA PLXNC1 NFKB1 VPS41 SMARCA2 CCT8 TAF2 DNM2	2.96e-05	1399	156	22	M535
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	UBR2 LIN7A IGF1R PTPRK PLXNC1 PIK3R1 SMARCA2 DNM2	3.41e-05	206	156	8	M2817
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	UBR2 LIN7A IGF1R PTPRK PLXNC1 PIK3R1 SMARCA2 DNM2	3.65e-05	208	156	8	MM581
Coexpression	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	SMOC2 NR2F2 GUCY1A1 ADAMTS9 TJP1 ARHGAP29 C1S CLMP	4.04e-05	211	156	8	M12225
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPERIC	MYO1C PARP14 TNFRSF21 NR2F2 SVEP1 CD4 PTPRK OLFML1 GUCY1A1 TJP1 COL21A1 KCNMB1 ARHGAP29 C1S NOSTRIN	8.49e-05	795	156	15	M39050
Coexpression	GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN	SEMA4D ATP10A ZFYVE28 PTPRO PLXNC1 MX1 DNMT3A	9.51e-05	177	156	7	M7632
Coexpression	HEVNER_CORTEX_ROSTRAL_CORTICAL_PLATE	FGF18 PTPRO SMARCA2 GNAL	1.13e-04	42	156	4	MM446
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TLK2 UBR2 CASP8 KIF20B NR2F2 TRIM33 PTPRA PTPRK ARHGEF7 SMARCA2 ARHGAP29	1.15e-04	466	156	11	M13522
Coexpression	IRITANI_MAD1_TARGETS_DN	IPO5 GGA2 RARS1 MCM6	1.49e-04	45	156	4	MM1263
Coexpression	IRITANI_MAD1_TARGETS_DN	IPO5 GGA2 RARS1 MCM6	1.62e-04	46	156	4	M1944
Coexpression	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	TLK2 SAMD9 PARP14 PNPT1 ADAMTS9 ATM MX1	1.84e-04	197	156	7	M7545
Coexpression	TERAMOTO_OPN_TARGETS_CLUSTER_7	RAPGEF6 METTL2A METTL2B	1.87e-04	19	156	3	MM524
Coexpression	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	REC8 SAMD9 POLE2 PARP14 ATP10A PNPT1 MX1	1.90e-04	198	156	7	M3302
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN	TLK2 SEMA4D SAMD9 PARP14 GPR180 PNPT1 MX1	1.90e-04	198	156	7	M4264
Coexpression	GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN	SAMD9 VPS45 PARP14 RAD50 PNPT1 PLXNC1 MX1	1.96e-04	199	156	7	M3311
Coexpression	GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN	RNMT POLE2 PARP14 ACKR4 ECE2 WDR62 CLBA1	1.96e-04	199	156	7	M7332
Coexpression	HALLMARK_MITOTIC_SPINDLE	RAPGEF6 ARHGAP10 CNTRL ARHGEF11 KIF20B ARHGEF7 ARHGAP29	1.96e-04	199	156	7	M5893
Coexpression	GSE11924_TFH_VS_TH17_CD4_TCELL_UP	CNTRL ZFYVE28 PBRM1 ZBED6 MCM9 COG4 WDR62	1.96e-04	199	156	7	M3156
Coexpression	GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP	RARS1 POLE2 CASP8 PSMD1 PTPRK CCT8 TPH1	2.02e-04	200	156	7	M4663
Coexpression	GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN	RNMT ERN1 PNPT1 IKBKE TJP1 C1S ATF1	2.02e-04	200	156	7	M5811
Coexpression	GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP	TLK2 RAPGEF6 TRIM33 PTPRK PIK3R1 NFKB1 MCM9	2.02e-04	200	156	7	M3251
Coexpression	GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP	IPO5 PSMD1 RNF14 NFKB1 MACF1 ATF1 ATP6V0A2	2.02e-04	200	156	7	M8290
Coexpression	GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN	GGA2 OGDH TNFRSF21 RAD50 ATP6V0D1 ATM ATP6V0A2	2.02e-04	200	156	7	M9613
Coexpression	GSE27786_LIN_NEG_VS_CD4_TCELL_UP	IPO5 CUL2 ACACA ZRANB3 NR2F2 PTPRK C9	2.02e-04	200	156	7	M4769
Coexpression	GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP	RAPGEF6 RARS1 VPS8 ARHGEF7 MACF1 CD302 TAF2	2.02e-04	200	156	7	M9889
Coexpression	GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN	RAP1A OGDH ATP10A TRIM33 ZNF106 TAF2 WDR62	2.02e-04	200	156	7	M8485
Coexpression	GSE17721_POLYIC_VS_CPG_6H_BMDC_UP	CASP8 MCM6 ATP9A MKNK1 ARHGEF7 ECE2 DNMT3A	2.02e-04	200	156	7	M3943
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN	TLK2 UBR2 ARHGAP10 ATP10A FGF18 TJP1 DNM2	2.02e-04	200	156	7	M3981
Coexpression	GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN	SEMA4D MYO1C PILRA POLE2 THRB C1S COG4	2.02e-04	200	156	7	M5088
Coexpression	HALLMARK_INTERFERON_GAMMA_RESPONSE	RAPGEF6 CASP8 PARP14 PNPT1 NFKB1 C1S MX1	2.02e-04	200	156	7	M5913
Coexpression	GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN	TLK2 DNAH2 PARP14 UBR7 PTPRA COG4 DNMT3A	2.02e-04	200	156	7	M7814
Coexpression	GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP	UBR2 RAPGEF6 CASP8 PARP14 RNF14 PNPT1 MX1	2.02e-04	200	156	7	M9051
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN	TLK2 SAMD9 PARP14 ARHGEF11 ATP10A GPR180 PNPT1	2.02e-04	200	156	7	M4269
Coexpression	GSE3982_NEUTROPHIL_VS_BASOPHIL_DN	CUL2 DPYSL2 RARS1 CNTRL PSMD1 PTPRO ATF1	2.02e-04	200	156	7	M5525
Coexpression	GSE20715_0H_VS_48H_OZONE_LUNG_UP	MYO1C ACKR4 FGF18 RAD50 PTPRO PLXNC1 CLBA1	2.02e-04	200	156	7	M4368
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	UBR2 SEMA4D RAP1A GGA2 RAPGEF6 SAMD9 CNTRL CASP8 PPHLN1 PARP14 JMY CARD8 ZBED5 ZFYVE28 TRIM33 CD4 PTPRA PIK3R1 SMARCA2 MACF1 ATM	2.15e-04	1492	156	21	M40023
Coexpression	BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP	SAMD9 RET PARP14 PNPT1 C1S CLMP MX1	2.28e-04	204	156	7	M34006
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	ATP10A IGF1R ADAMTS9 PTPRO TJP1 SBF2 MACF1	2.89e-04	212	156	7	M39221
Coexpression	NAKAMURA_ADIPOGENESIS_LATE_UP	ACACA TNFRSF21 CCNG1 PPP2R5A PTPRA	3.05e-04	98	156	5	M2026
Coexpression	DESCARTES_FETAL_MUSCLE_STROMAL_CELLS	SMOC2 ITPRID1 ACKR4 FGF18 C1S	3.19e-04	99	156	5	M40255
Coexpression	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	GGA2 CASP8 PLXNC1 SMARCA2	3.49e-04	56	156	4	M14036
Coexpression	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	UBR2 ACACA MYO1C MCM6 RET PTPRK IKBKE	4.02e-04	224	156	7	M2500
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CCDC146 CNTRL PSMD1 KIF20B RAD50 TRIM33 ZNF106 TJP1 SMARCA2 CCT8	2.18e-09	198	156	10	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK2 UBR2 SAMD9 RNMT CASP8 PARP14 PIK3R1 MACF1 ATM MX1	2.40e-09	200	156	10	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19-Heart-Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ARHGAP10 TRPC4 SMOC2 NR2F2 LIN7A GUCY1A1 ADAMTS9 ARHGEF7	2.57e-07	181	156	8	33cac65ed1ea5e7bd72250495df4f850b143d5aa
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	KALRN ARHGAP10 ITPRID1 NR2F2 LIN7A GUCY1A1 ADAMTS9 ARHGEF7	3.03e-07	185	156	8	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	SMOC2 NR2F2 SVEP1 OLFML1 ADAMTS9 C1S CLMP GNAL	3.29e-07	187	156	8	e04fb35f2f5b120659d06b5ae427ab1ec56d5c36
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR2F2 SVEP1 PPP4R4 OLFML1 MACF1 C1S CD302 CLMP	3.71e-07	190	156	8	00fd993675faf53adf985b9316a18c8a33242029
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN TRPC4 SMOC2 ATP10A NR2F2 SVEP1 GUCY1A1 COL21A1	3.71e-07	190	156	8	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	NR2F2 IGF1R THRB GUCY1A1 COL21A1 SMARCA2 MACF1 CD302	3.71e-07	190	156	8	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR2F2 SVEP1 PPP4R4 OLFML1 MACF1 C1S CD302 CLMP	3.71e-07	190	156	8	8cda09d761c6b504a744959d587c183f94f1beeb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 ATP10A NR2F2 GUCY1A1 ARHGEF7	3.86e-07	191	156	8	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 ATP10A NR2F2 GUCY1A1 ARHGEF7	3.86e-07	191	156	8	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 NR2F2 SVEP1 C1S CLMP	4.02e-07	192	156	8	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 NR2F2 SVEP1 C1S CLMP	4.02e-07	192	156	8	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	SPTLC2 ATP9A TRIM33 PBRM1 PTPRK ZBED6 SBF2 CD302	4.18e-07	193	156	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 ATP10A NR2F2 SVEP1 COL21A1	4.52e-07	195	156	8	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 NR2F2 SVEP1 C1S CLMP	4.52e-07	195	156	8	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 ATP10A NR2F2 SVEP1 COL21A1	4.52e-07	195	156	8	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 NR2F2 SVEP1 C1S CLMP	4.52e-07	195	156	8	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	ASK428-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	REC8 SAMD9 MCM6 SMOC2 TNFRSF21 ADAMTS9 ARHGAP29 C1S	4.52e-07	195	156	8	c750602c765a51075ba6ede78e3ba80b62374481
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 ATP10A NR2F2 ARHGEF7 COL21A1	4.70e-07	196	156	8	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMOC2 NR2F2 SVEP1 PPP4R4 PIK3R1 MACF1 CD302 CLMP	4.88e-07	197	156	8	06a0d7062dadda656decaf77dcef9a10b5f2698d
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMOC2 NR2F2 SVEP1 PPP4R4 PIK3R1 MACF1 CD302 CLMP	4.88e-07	197	156	8	d35c7a36135b5ed6a7bf2f934849678eba2a0177
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 ATP10A SVEP1 COL21A1 CLMP	5.07e-07	198	156	8	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SMOC2 ACKR4 TNFRSF21 SVEP1 PTPRK OLFML1 GUCY1A1 CLMP	5.07e-07	198	156	8	12cd9f0bbad8dce5199ebfed1c4a8080710ca055
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACKR4 TNFRSF21 ZNF106 OLFML1 GUCY1A1 TJP1 PIK3R1 MDGA1	5.27e-07	199	156	8	eeb7d370d4dfacf705306c72ccc4919ddefacff1
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DPYSL2 ATP8A2 SVEP1 ZNF106 COL21A1 MACF1 C1S CD302	5.27e-07	199	156	8	212e89d097753790061310373a1fafba773488b6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DPYSL2 ATP8A2 SVEP1 ZNF106 COL21A1 MACF1 C1S CD302	5.27e-07	199	156	8	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NR2F2 SVEP1 OLFML1 COL21A1 MACF1 C1S CD302 CLMP	5.47e-07	200	156	8	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SPTLC2 PARP14 TNFRSF21 ADAMTS9 TJP1 ARHGAP29 NOSTRIN MX1	5.47e-07	200	156	8	3585484c7e24e941708bee471ca607d8ccee74e6
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NR2F2 SVEP1 OLFML1 COL21A1 MACF1 C1S CD302 CLMP	5.47e-07	200	156	8	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Healthy/Control-RBC\|World / Disease group and Cell class	SPTA1 CCDC150 ADAMTS13 PTPRK C1S WDR62 TPH1	1.57e-06	160	156	7	f10871238e7bdf3e1f65a17070000477196e50fe
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	KALRN SMOC2 ATP10A NR2F2 ADAMTS9 ARHGEF7 KCNMB1	1.64e-06	161	156	7	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SEMA4D RAPGEF6 JMY NFKB1 MACF1 ATM LIPI	2.45e-06	171	156	7	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	KALRN SMOC2 ATP10A GUCY1A1 ADAMTS9 ARHGEF7 KCNMB1	2.45e-06	171	156	7	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	KALRN ARHGAP10 ATP10A LIN7A GUCY1A1 ADAMTS9 ARHGEF7	3.57e-06	181	156	7	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	facs-Heart-LV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFRSF21 NR2F2 LIN7A PTPRK GUCY1A1 KCNMB1 NOSTRIN	3.57e-06	181	156	7	1db1eb7d330a7e5090994007ae287e11f0a74450
ToppCell	facs-Heart-LV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFRSF21 NR2F2 LIN7A PTPRK GUCY1A1 KCNMB1 NOSTRIN	3.57e-06	181	156	7	06174ce9240c9261c0f51a1b0d875335d60722e5
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	KALRN ARHGAP10 ATP10A LIN7A GUCY1A1 ADAMTS9 ARHGEF7	3.70e-06	182	156	7	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	KALRN ARHGAP10 TRPC4 ATP10A GUCY1A1 ADAMTS9 ARHGEF7	3.84e-06	183	156	7	818fd886e0188091310825f9145fa53328f2c979
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	KALRN ARHGAP10 NR2F2 LIN7A GUCY1A1 ADAMTS9 ARHGEF7	3.84e-06	183	156	7	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	KALRN ARHGAP10 NR2F2 LIN7A GUCY1A1 ADAMTS9 ARHGEF7	3.84e-06	183	156	7	273db6a3b00a93ca852498471187b642b5368185
ToppCell	COVID-19-Heart-Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ARHGAP10 TRPC4 NR2F2 LIN7A GUCY1A1 ADAMTS9 ARHGEF7	3.98e-06	184	156	7	21790cdfa3b4036ad413fd44b94e31563116f25f
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	ARHGAP10 TRPC4 NR2F2 LIN7A GUCY1A1 ADAMTS9 TJP1	4.12e-06	185	156	7	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	LV-07._Pericyte\|LV / Chamber and Cluster_Paper	KALRN ARHGAP10 NR2F2 LIN7A GUCY1A1 ADAMTS9 ARHGEF7	4.12e-06	185	156	7	acb38eba871ec72f2a8136a33b87d33b8c85465d
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	KALRN ARHGAP10 NR2F2 LIN7A GUCY1A1 ADAMTS9 ARHGEF7	4.42e-06	187	156	7	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SAMD9 ARHGAP10 CNTRL PARP14 ATP10A PNPT1 MX1	4.42e-06	187	156	7	72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC4 SMOC2 NR2F2 SVEP1 C1S CLMP DNAH8	4.74e-06	189	156	7	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC4 SMOC2 NR2F2 SVEP1 C1S CLMP DNAH8	4.74e-06	189	156	7	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR2F2 SVEP1 OLFML1 MACF1 C1S CD302 CLMP	4.74e-06	189	156	7	324c81285c51f4f8bb1aef428b18fe2c549c2c11
ToppCell	droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR173 SMOC2 ACKR4 SVEP1 C1S CD302 CLMP	4.91e-06	190	156	7	8cb950effc449ae59a915132ecc079be54d1acfe
ToppCell	droplet-Pancreas-Exocrine-24m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR173 SMOC2 ACKR4 SVEP1 C1S CD302 CLMP	4.91e-06	190	156	7	5dfbd064ab1f8a0b18b5975c47f8e79697f3db15
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	ATP8A2 ZNF106 CD4 GUCY1A1 PIK3R1 MACF1 CD302	4.91e-06	190	156	7	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR173 SMOC2 ACKR4 SVEP1 C1S CD302 CLMP	4.91e-06	190	156	7	17a73a658fb30a4322b31e38db7b240023738f29
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMOC2 ACKR4 SVEP1 OLFML1 C1S CD302 CLMP	5.26e-06	192	156	7	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMOC2 ACKR4 SVEP1 OLFML1 C1S CD302 CLMP	5.26e-06	192	156	7	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMOC2 ACKR4 SVEP1 OLFML1 C1S CD302 CLMP	5.26e-06	192	156	7	ac1477433704573f95111eee6263b93668d2845e
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SMOC2 ACKR4 TNFRSF21 SVEP1 OLFML1 GUCY1A1 CLMP	5.26e-06	192	156	7	20ede290e01ad574afd122d72b59dbc52c595fad
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SMOC2 ACKR4 TNFRSF21 PTPRK OLFML1 GUCY1A1 PIK3R1	5.44e-06	193	156	7	7cd9671e0ac64f7f3607f564485c63abbb7e7a63
ToppCell	PND28-Mesenchymal-Mesenchymal_structural\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMOC2 NR2F2 SVEP1 OLFML1 MACF1 C1S CD302	5.44e-06	193	156	7	ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NR2F2 SVEP1 PPP4R4 OLFML1 MACF1 C1S CLMP	5.44e-06	193	156	7	4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SMOC2 ACKR4 TNFRSF21 PTPRK GUCY1A1 PIK3R1 CLMP	5.44e-06	193	156	7	96c85b250d04b5f400512097d925061c6dc2906b
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NR2F2 SVEP1 PPP4R4 OLFML1 MACF1 C1S CLMP	5.44e-06	193	156	7	ff8ceeb3cfd1bef7239df490c19d181091750833
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 SVEP1 C1S CLMP	5.44e-06	193	156	7	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 SVEP1 C1S CLMP	5.44e-06	193	156	7	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMOC2 NR2F2 SVEP1 OLFML1 MACF1 C1S CD302	5.44e-06	193	156	7	30481fb01c7acf85beae10213f038da86bed6777
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN TRPC4 SMOC2 NR2F2 SVEP1 C1S CLMP	5.63e-06	194	156	7	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 ATP10A NR2F2 COL21A1	5.63e-06	194	156	7	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	PND01-Mesenchymal-Mesenchymal_structural\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMOC2 NR2F2 SVEP1 PPP4R4 MACF1 CD302 CLMP	5.82e-06	195	156	7	6bb6349d6ec8da094fe1c7c590021989337aeb0b
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMOC2 NR2F2 SVEP1 PPP4R4 MACF1 CD302 CLMP	5.82e-06	195	156	7	a3b468125e48f072255cede7645f6692298ecf54
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRPC4 TNFRSF21 NR2F2 OLFML1 GUCY1A1 ARHGAP29 NOSTRIN	6.02e-06	196	156	7	cb61757646653f89faba503cb5d99e5dd5197b4c
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACKR4 TNFRSF21 ZNF106 OLFML1 GUCY1A1 TJP1 PIK3R1	6.02e-06	196	156	7	308fa54385ca34e9e590967d4553b84aad96c92f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 SVEP1 C1S CLMP	6.02e-06	196	156	7	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 SVEP1 C1S CLMP	6.02e-06	196	156	7	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	IPF-Stromal-Pericyte\|IPF / Disease state, Lineage and Cell class	TRPC4 SMOC2 NR2F2 LIN7A GUCY1A1 ADAMTS9 C1S	6.02e-06	196	156	7	8b6ff47ce5291d223f5e639fc45cd9267f418256
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRPC4 SMOC2 NR2F2 OLFML1 GUCY1A1 ARHGAP29 NOSTRIN	6.02e-06	196	156	7	12d9028f90c057c6e5cff00301793fa550e86c5a
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRPC4 TNFRSF21 NR2F2 OLFML1 GUCY1A1 ARHGAP29 NOSTRIN	6.02e-06	196	156	7	44e2df1b61e3819eae7e482bef0a733afe852d67
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN ARHGAP10 TRPC4 SMOC2 SVEP1 C1S CLMP	6.22e-06	197	156	7	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 TRPC4 ATP10A NR2F2 OLFML1 GUCY1A1 COL21A1	6.22e-06	197	156	7	bc6c530330907a5ec823cc243c8e9c9e340cfb9c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN TRPC4 SMOC2 NR2F2 SVEP1 C1S CLMP	6.22e-06	197	156	7	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KALRN TRPC4 SMOC2 NR2F2 SVEP1 C1S CLMP	6.22e-06	197	156	7	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 TRPC4 ATP10A NR2F2 OLFML1 GUCY1A1 COL21A1	6.22e-06	197	156	7	77fe092aae8f05fe137680506892d2f61071d6ea
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 TRPC4 SMOC2 NR2F2 SVEP1 COL21A1 CLMP	6.22e-06	197	156	7	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NR2F2 SVEP1 OLFML1 GUCY1A1 C1S CLMP GNAL	6.22e-06	197	156	7	ea9332adf753d7e92f89654320543abb9e6142aa
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-G\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	DPYSL2 ATP8A2 SVEP1 COL21A1 MACF1 C1S CD302	6.22e-06	197	156	7	a21a710c824f9e5c7ef1674168d1ce5aef85bd35
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-T_reticular\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NR2F2 SVEP1 OLFML1 GUCY1A1 C1S CLMP GNAL	6.43e-06	198	156	7	11f21a4a97da10fc6ae604cb627aa3af749d9dff
ToppCell	distal-2-mesenchymal-Vascular_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SMOC2 NR2F2 OLFML1 GUCY1A1 COL21A1 C1S RASL10B	6.43e-06	198	156	7	ce05ede69c167b2294630709bb0c223483a6ef75
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK2 UBR2 CASP8 PARP14 PIK3R1 MACF1 ATM	6.65e-06	199	156	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	control-CD163+_Monocytes_(Sample_ID1_d7)\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF130 DPYSL2 PILRA SPTLC2 PARP14 PNPT1 MX1	6.65e-06	199	156	7	933201d32eda12a89660bdbae9114a95cc428a38
ToppCell	medial-mesenchymal-Vascular_Smooth_Muscle\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SMOC2 NR2F2 OLFML1 GUCY1A1 COL21A1 C1S RASL10B	6.65e-06	199	156	7	74fe1737a0d63ef0bc49312f1b5823b5c39590dd
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NR2F2 SVEP1 COL21A1 MACF1 C1S CD302 CLMP	6.65e-06	199	156	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	medial-2-mesenchymal-Vascular_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SMOC2 NR2F2 OLFML1 GUCY1A1 COL21A1 C1S RASL10B	6.65e-06	199	156	7	8ce0bcc53b3a955285d614459e45210104a6ed02
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SMOC2 ACKR4 NR2F2 OLFML1 PIK3R1 SMARCA2 C1S	6.65e-06	199	156	7	9846d6a31635fde759d55674631c11ab9270a603
ToppCell	Fibroblasts-CD34+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SMOC2 NR2F2 SVEP1 OLFML1 GUCY1A1 C1S GNAL	6.65e-06	199	156	7	13ff7409e200a0b46cdb7924d15ef33639693622
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NR2F2 SVEP1 COL21A1 MACF1 C1S CD302 CLMP	6.65e-06	199	156	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	medial-mesenchymal-Vascular_Smooth_Muscle-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SMOC2 NR2F2 OLFML1 GUCY1A1 COL21A1 C1S RASL10B	6.65e-06	199	156	7	263603264ff40ea8ef569cb43f8b84b5938438ab
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SPTLC2 PARP14 PPP2R5A TJP1 ARHGAP29 MACF1 NOSTRIN	6.87e-06	200	156	7	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PARP14 PPP2R5A GUCY1A1 TJP1 ARHGAP29 MACF1 MX1	6.87e-06	200	156	7	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KALRN ARHGAP10 TRPC4 SMOC2 NR2F2 LIN7A ADAMTS9	6.87e-06	200	156	7	9d3ae9ea47b1017adb63aa02d10e98193d478458
ToppCell	Tracheal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KALRN ARHGAP10 TRPC4 SMOC2 NR2F2 LIN7A ADAMTS9	6.87e-06	200	156	7	78cd0b7d221ef855512ee9ac9a291f61622c2e24
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SPTLC2 PARP14 PPP2R5A TJP1 ARHGAP29 MACF1 NOSTRIN	6.87e-06	200	156	7	4bb609a284d4e6066f17470a1736076aa4a1f84c
Drug	Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A	SEMA4D RARS1 RIBC2 ATP8A2 ATP10A NR2F2 PPP4R4 PIK3R1 CCT6B C1S CLBA1	1.07e-07	196	155	11	2097_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	GGA2 RARS1 RET NR2F2 MKNK1 PPP2R5A MCM9 ATM DNM2	4.93e-06	184	155	9	1064_DN
Drug	SC-560; Up 200; 10uM; PC3; HT_HG-U133A	GGA2 SAMD9 CNTRL ATP10A SVEP1 IGF1R COL21A1 SMARCA2 CLBA1	8.23e-06	196	155	9	6865_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A	GGA2 FGF18 PPP4R4 RAD50 CD4 PLXNC1 CCT6B OGDHL MX1	8.23e-06	196	155	9	4439_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A	GGA2 RIBC2 CASP8 IGF1R PLXNC1 PIK3R1 MX1 DNM2 TCTN2	8.23e-06	196	155	9	4540_DN
Disease	Intellectual Disability	TLK2 RARS1 ATP8A2 UBR7 FCSK PNPT1 EIF2S3 MACF1 TAF2 WDR62 DNMT3A	2.18e-05	447	152	11	C3714756
Disease	MEHMO syndrome (implicated_via_orthology)	EIF2S3B EIF2S3	2.64e-05	2	152	2	DOID:0060801 (implicated_via_orthology)
Disease	oxoglutarate dehydrogenase deficiency (implicated_via_orthology)	OGDH OGDHL	2.64e-05	2	152	2	DOID:0081326 (implicated_via_orthology)
Disease	African Burkitt's lymphoma	RET PIK3R1 CCT6B	5.83e-05	15	152	3	C0343640
Disease	Burkitt Leukemia	RET PIK3R1 CCT6B	5.83e-05	15	152	3	C4721444
Disease	spleen volume	SPTA1 CASP8 TJP1 ATF1	7.14e-05	43	152	4	EFO_0600047
Disease	Gastric Adenocarcinoma	TLK2 ERN1 WEE2 ATM	8.56e-05	45	152	4	C0278701
Disease	neurodegenerative disease (implicated_via_orthology)	UBR2 GGA2 TRPC4 OGDH NFKB1 OGDHL	1.09e-04	145	152	6	DOID:1289 (implicated_via_orthology)
Disease	diastolic blood pressure, systolic blood pressure	RNMT TRPC4 DNAH2 PSMD1 PPHLN1 SMOC2 TRIM33 PNPT1 PLXNC1 COL21A1 TAF2 WDR62	1.93e-04	670	152	12	EFO_0006335, EFO_0006336
Disease	hepatocellular carcinoma (biomarker_via_orthology)	CASP8 CCNG1 PIK3R1 NFKB1 DNMT3A	2.47e-04	108	152	5	DOID:684 (biomarker_via_orthology)
Disease	centronuclear myopathy 1 (implicated_via_orthology)	MX1 DNM2	2.61e-04	5	152	2	DOID:0111223 (implicated_via_orthology)
Disease	microcytic anemia (implicated_via_orthology)	MX1 DNM2	2.61e-04	5	152	2	DOID:11252 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology)	MX1 DNM2	2.61e-04	5	152	2	DOID:0110197 (implicated_via_orthology)
Disease	melanoma	REC8 CASP8 RET CUBN PTPRK PTPRO ATM	3.13e-04	248	152	7	C0025202
Disease	myeloid white cell count	UBR2 RAP1A RNMT MYO1C VPS8 CASP8 MCM6 PTPRA GUCY1A1 NFKB1 SBF2 NOSTRIN DNMT3A TPH1	3.64e-04	937	152	14	EFO_0007988
Disease	hypopituitarism (implicated_via_orthology)	EIF2S3B EIF2S3	3.90e-04	6	152	2	DOID:9406 (implicated_via_orthology)
Disease	lung small cell carcinoma (is_implicated_in)	PBRM1 PIK3R1 ATM	3.99e-04	28	152	3	DOID:5409 (is_implicated_in)
Disease	glucose metabolism disease (implicated_via_orthology)	EIF2S3B IGF1R EIF2S3	3.99e-04	28	152	3	DOID:4194 (implicated_via_orthology)
Disease	Microcephaly	DNM1L EIF2S3 WDR62 DNMT3A	4.03e-04	67	152	4	C0025958
Disease	Malignant neoplasm of breast	KALRN RIBC2 TRPC4 CASP8 PPHLN1 CUBN CRHR1 GPR180 IGF1R PBRM1 ARHGAP29 MACF1 ATM RASL10B DNMT3A	4.54e-04	1074	152	15	C0006142
Disease	Severe Congenital Microcephaly	DNM1L WDR62 DNMT3A	5.42e-04	31	152	3	C3853041
Disease	cortical surface area measurement	SEMA4D DPYSL2 SAMD9 ATP8A2 SMOC2 ACKR4 KIF20B FGF18 CRHR1 NR2F2 SVEP1 ZNF106 ADAMTS9 TJP1 PIK3R1 NFKB1 MACF1	5.89e-04	1345	152	17	EFO_0010736
Disease	obsolete_red blood cell distribution width	SAMD9 KALRN PILRA SPTLC2 SPTA1 MCM6 TRIM33 IGF1R PBRM1 PTPRA THRB ZBED6 PIK3R1 SMARCA2 C1S CLMP DNM2	5.99e-04	1347	152	17	EFO_0005192
Disease	Microlissencephaly	DNM1L WDR62 DNMT3A	6.53e-04	33	152	3	C1956147
Disease	cortical thickness	SEMA4D DPYSL2 SMOC2 KIF20B FGF18 CRHR1 NR2F2 ZNF106 IGF1R ADAMTS9 PLXNC1 COL21A1 PIK3R1 NFKB1 MACF1	6.56e-04	1113	152	15	EFO_0004840
Disease	neuroimaging measurement, brain volume measurement	DPYSL2 ITPRID1 ARHGEF11 PBRM1 SMARCA2 ATF1 NOSTRIN	7.31e-04	286	152	7	EFO_0004346, EFO_0006930
Disease	Burkitt Lymphoma	RET PIK3R1 CCT6B	8.45e-04	36	152	3	C0006413
Disease	influenza A severity measurement	ZFYVE28 GUCY1A1	9.27e-04	9	152	2	EFO_0007743
Disease	leukodystrophy (implicated_via_orthology)	EIF2S3B EIF2S3	9.27e-04	9	152	2	DOID:10579 (implicated_via_orthology)
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	NFKB1 SMARCA2	9.27e-04	9	152	2	DOID:0050340 (implicated_via_orthology)
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	DNM1L CRHR1 IGF1R PIK3R1 KCNMB1	1.01e-03	147	152	5	DOID:9352 (biomarker_via_orthology)
Disease	lung cancer (is_marker_for)	CCNG1 NFKB1 DNMT3A	1.07e-03	39	152	3	DOID:1324 (is_marker_for)
Disease	lactose measurement	MCM6 ZNF106	1.15e-03	10	152	2	EFO_0010507
Disease	Human papillomavirus infectious disease (is_marker_for)	CCNG1 MX1	1.15e-03	10	152	2	DOID:11166 (is_marker_for)
Disease	Peripheral T-Cell Lymphoma	ATM DNMT3A	1.15e-03	10	152	2	C0079774
Disease	Diaphragmatic Hernia	FGF18 NR2F2 THRB	1.24e-03	41	152	3	C0019284
Disease	fructose measurement, glucose measurement, galactose measurement	TNFRSF21 THRB	1.68e-03	12	152	2	EFO_0004468, EFO_0010477, EFO_0010481
Disease	status epilepticus (biomarker_via_orthology)	DPYSL2 CASP8 SLC8A2 ATM	1.81e-03	100	152	4	DOID:1824 (biomarker_via_orthology)
Disease	platelet component distribution width	KALRN SPTA1 DNM1L CUBN SMOC2 JMY SVEP1 TRIM33 IGF1R THRB MACF1	1.90e-03	755	152	11	EFO_0007984
Disease	brain ischemia (biomarker_via_orthology)	DPYSL2 RET SLC8A2 TJP1	1.94e-03	102	152	4	DOID:2316 (biomarker_via_orthology)
Disease	fatty acid measurement	ANKRD31 UBR2 SEMA4D ATP8A2 MCM6 JMY PIK3R1 MACF1	1.97e-03	436	152	8	EFO_0005110
Disease	developmental and epileptic encephalopathy (implicated_via_orthology)	MX1 DNM2	1.98e-03	13	152	2	DOID:0112202 (implicated_via_orthology)
Disease	red blood cell density measurement	KALRN SPTA1 DNAH2 ARHGEF11 KIF20B TRIM33 ZNF106 PBRM1 THRB PIK3R1 SBF2 DNMT3A	2.07e-03	880	152	12	EFO_0007978
Disease	Alzheimer's disease (is_marker_for)	CASP8 DNM1L CCNG1 SLC8A2 IGF1R ATM	2.22e-03	257	152	6	DOID:10652 (is_marker_for)
Disease	hepatocellular carcinoma (is_implicated_in)	ERN1 CASP8 CCNG1 IGF1R NFKB1	2.52e-03	181	152	5	DOID:684 (is_implicated_in)
Disease	skin aging measurement	SEMA4D CASP8 PNPT1 ARHGEF7 SBF2	2.52e-03	181	152	5	EFO_0008006
Disease	Glioblastoma Multiforme	ERN1 TRIM33 PIK3R1 TAF1L	2.64e-03	111	152	4	C1621958
Disease	cancer (implicated_via_orthology)	IPO5 RET PPP2R5A SMARCA2 MACF1 ATM	2.73e-03	268	152	6	DOID:162 (implicated_via_orthology)
Disease	pancreatic cancer (is_implicated_in)	CASP8 CCNG1 IGF1R ATM	2.73e-03	112	152	4	DOID:1793 (is_implicated_in)
Disease	left ventricular diastolic function measurement	MYO1C IGF1R PIK3R1	2.74e-03	54	152	3	EFO_0008204
Disease	mean reticulocyte volume	SAMD9 SPTA1 DNAH2 TRIM33 PTPRA THRB PIK3R1 NFKB1 C1S ATM CHMP1A	2.94e-03	799	152	11	EFO_0010701
Disease	dual specificity mitogen-activated protein kinase kinase 2 measurement	PPP4R4 PCID2	3.02e-03	16	152	2	EFO_0008112
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	ARHGAP29 ATM	3.02e-03	16	152	2	C0334634
Disease	thyroid volume	IGF1R SMARCA2	3.02e-03	16	152	2	EFO_0004865
Disease	Bipolar Disorder	DPYSL2 CASP8 CRHR1 PBRM1 GNAL MDGA1 DNAH8 TPH1	3.41e-03	477	152	8	C0005586
Disease	monocyte count	MYO1C KALRN PILRA SPTA1 CASP8 MCM6 EIF2S3B OGDH ZFYVE28 PTPRA THRB NFKB1 ATM NOSTRIN METTL2B	3.46e-03	1320	152	15	EFO_0005091
Disease	age at menarche	SEMA4D DNAH2 FAAH2 IGF1R THRB PTPRK SMARCA2 NOSTRIN ECE2	3.77e-03	594	152	9	EFO_0004703
Disease	Feeding difficulties	RARS1 FCSK	3.82e-03	18	152	2	C0232466
Disease	protein Z-dependent protease inhibitor measurement	PPP4R4 PCID2	3.82e-03	18	152	2	EFO_0021849
Disease	hypertension, white matter hyperintensity measurement	RIBC2 PNPT1 ZNF106	4.06e-03	62	152	3	EFO_0000537, EFO_0005665
Disease	superior temporal gyrus volume measurement	CUBN RNF14	4.26e-03	19	152	2	EFO_0010331
Disease	polycystic kidney disease (biomarker_via_orthology)	ATF1 C9	4.26e-03	19	152	2	DOID:0080322 (biomarker_via_orthology)
Disease	Adenocarcinoma of lung (disorder)	IPO5 ERN1 TRIM33 ATM TAF1L	4.37e-03	206	152	5	C0152013
Disease	hypertension (implicated_via_orthology)	CRHR1 NR2F2 PIK3R1 KCNMB1	4.41e-03	128	152	4	DOID:10763 (implicated_via_orthology)
Disease	neutrophil percentage of leukocytes	UBR2 KALRN SPTA1 CASP8 MCM6 RAD50 NFKB1 ZNF565 DNMT3A	4.48e-03	610	152	9	EFO_0007990
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	ACACA ADAMTS13 IGF1R	4.63e-03	65	152	3	DOID:0080208 (biomarker_via_orthology)
Disease	heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer	DNAH2 MX1	4.71e-03	20	152	2	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992
Disease	Fetal Growth Retardation	SAMD9 IGF1R	4.71e-03	20	152	2	C0015934
Disease	cortisol measurement	MKNK1 CNTNAP5	4.71e-03	20	152	2	EFO_0005843
Disease	vital capacity	SEMA4D MYO1C ATP9A JMY FGF18 SVEP1 PNPT1 ZNF106 IGF1R COL21A1 PIK3R1 SMARCA2 ZNF565 COG4	4.83e-03	1236	152	14	EFO_0004312
Disease	sexual dimorphism measurement	ANKRD31 RAPGEF6 ADAMTS13 SMOC2 FGF18 PNPT1 IGF1R PIK3R1 MACF1 ATF1 NOSTRIN ATP6V0A2 DNMT3A	4.85e-03	1106	152	13	EFO_0021796
Disease	Liver carcinoma	ACACA CASP8 ADAMTS13 PNPT1 IGF1R ATM C9 WDR62	4.90e-03	507	152	8	C2239176
Disease	household income	SAMD9 KALRN CRHR1 PIK3R1 MCM9 SMARCA2	5.04e-03	304	152	6	EFO_0009695
Disease	Global developmental delay	RARS1 FCSK PNPT1 IGF1R	5.04e-03	133	152	4	C0557874

Protein segments in the cluster

Peptide	Gene	Start	Entry
ELTRACQKQYELEQE	CNTRL	341	Q7Z7A1
QRDCEVIERLIKSYF	DNM1L	641	O00429
YEVRQKCRNIEDICI	DNMT3A	481	Q9Y6K1
TLIKYLQVECDRQVE	COG4	301	Q9H9E3
QEIVRDIKEKLCYVA	POTEKP	206	Q9BYX7
CYIFLQEAIKVESIE	CD302	36	Q8IX05
DQCREILKYVNEAVK	ARHGEF11	911	O15085
KNDQCYEDIRVSRVT	CORO1B	21	Q9BR76
SVIEENIKCISRDYV	ACACA	2286	Q13085
QYCTQEITVFREDLV	POLE2	406	P56282
VLIQCAGSEEKNERY	ARHGEF7	486	Q14155
VTYDRRCTVEQINKF	AP5Z1	656	O43299
RCTVEQINKFFEALE	AP5Z1	661	O43299
RAQRLEECYEIIEKN	ATP8A2	656	Q9NTI2
IEIVKACQVYFINQD	ATP10A	381	O60312
VNYSCLDQARKELVE	ADAMTS13	706	Q76LX8
REYLRVNVVKTCEEI	REC8	31	O95072
IEDSYRKQVEVDCQQ	RAP1A	36	P62834
FYRIKKNIDQCSEIV	RAD50	1286	Q92878
SLQEKSQCALEEYVR	NR2F2	336	P24468
VCIESYKQNDVVRIL	RNF130	266	Q86XS8
EKVRAKFQEQQVFYC	KCNMB1	121	Q16558
REYYVQQEVIVLFCE	ZFYVE28	186	Q9HCC9
QYELICIKEDVREFA	ACKR4	26	Q9NPB9
CFYLAVKSIEEERNV	CCNG1	101	P51959
NVECARVYAENAIRK	CHMP1A	41	Q9HD42
CDTERNYIDRDQKII	ANKRD31	1061	Q8N7Z5
CVVKEDNISERVYTI	MDGA1	36	Q8NFP4
ELSLEYVCKLQEIQE	ARHGAP10	176	A1A4S6
CQTVIRDVEQQFKYT	MCM6	161	Q14566
VELQQFFIKIRDELC	PBRM1	866	Q86U86
VLQSEFCTAIREVYQ	LIN7A	56	O14910
QLYEVQFEILKCEEL	JMY	536	Q8N9B5
KTICQSFREYLEEIE	ITPRID1	871	Q6ZRS4
EVVRNCISFIFENKI	SBF2	551	Q86WG5
KDRFQLTDCQIYEVL	DPYSL2	171	Q16555
VFQEECVQKYQASLV	IKBKE	591	Q14164
QRFYLSCLQVERIEE	ECE2	221	P0DPD6
EIKYGSQVEDQRECV	IGF1R	866	P08069
NVTVKLRVQDTYLDC	PLXNC1	821	O60486
RNTFNKDVVVDLVCY	OGDHL	481	Q9ULD0
DYNIVCSSEIKRQVV	DNAH8	2996	Q96JB1
ECVFIEKVLENNYTA	FGF18	126	O76093
VAVLYCFLNKEVQSE	GCGR	396	P47871
QKVEEAIQQYERACK	KIF20B	1351	Q96Q89
LDQCQQYVVFERSAK	KALRN	1126	O60229
ENSIQRVCQEKQVDY	METTL2B	56	Q6P1Q9
VQRFEIAKYCSSDQV	PI4KAP1	46	Q8N8J0
DQEALQVVYERCEKL	GGA2	261	Q9UJY4
AVEEIRCYVRDKEVN	ATP9A	121	O75110
CISVIFSDYQRDKVI	GPR180	376	Q86V85
IKIFEEQCQTQERYS	PIK3R1	491	P27986
KEEAVQTFNYLCDLI	IPO5	1006	O00410
EQKCAEALYTETRLQ	RIBC2	181	Q9H4K1
VYKDLRQIELACDSQ	DNM2	596	P50570
RDKLIDCYTFLQAEV	ERVK-7	206	P63135
ISVKAVCDYRQIEIT	MACF1	871	Q9UPN3
LEKCTQATRAYIQEF	OLFML1	46	Q6UWY5
ENSIQRVCQEKQVDY	METTL2A	56	Q96IZ6
EVIESFQVEKCVTEY	NUTM1	741	Q86Y26
QQFCISDVIYENVSK	PTPRO	1201	Q16827
VKACFERSNEYQLID	GNAL	146	P38405
KRLFGCYIELQENEV	PARP14	766	Q460N5
VIRKELEQIFCQFDS	OGDH	321	Q02218
DFIEAYKCQTVIVQS	PCID2	76	Q5JVF3
QKQDQSVYFCRVELD	PILRA	116	Q9UKJ1
NELYKVCVTNVEERR	ARHGAP29	386	Q52LW3
KAEYRQTCENVVIVN	CUBN	1271	O60494
CQYKDSVQVFQRELE	FCSK	16	Q8N0W3
INVETKERNRYCLEL	GSKIP	66	Q9P0R6
TYLNNTLVEDCVKVR	ATM	1716	Q13315
RYRKVVCVDDNKNEV	ADAMTS9	1576	Q9P2N4
KNYEQSLSIQRFVCE	CCDC150	936	Q8NCX0
TEKDRQFQYIAIELC	ERN1	631	O75460
VILYELENFQGKRCE	CRYBB3	26	P26998
CIEVLIDKQYIERSQ	CUL2	721	Q13617
SKVCFEIEEDYKNRQ	CARD8	146	Q9Y2G2
RCEYQIRLEKGFQVV	C1S	201	P09871
TYICEVEDQKEEVQL	CD4	106	P01730
EETVQFDVQKLRIYC	COL21A1	396	Q96P44
RVNYSECQEILNEEK	CRHR1	96	P34998
DCTVEQIYEILKIYQ	CASP8	286	Q14790
KCIDVVQAYINRIKD	FAAH2	66	Q6GMR7
DVGTYKFIREEDQCI	GPR173	161	Q9NS66
TDIADVSVKQCQQRY	RNMT	226	O43148
AQLKYNIEVVCEYIV	EIF2S3B	226	Q2VIR3
AEFQKQCEEYLVIIV	DNAH2	3036	Q9P225
QCEEYLVIIVQQKRE	DNAH2	3041	Q9P225
SKTKEIEQVYRQDCE	PPHLN1	296	Q8NEY8
IDLQNTVSECKREYF	CNTNAP5	1291	Q8WYK1
RAIEDYINEFSVRKC	C9	496	P02748
VDYTVRKFCIQQVGD	PTPRA	376	P18433
RLQEVTKTDQDLYRC	PTPRK	256	Q15262
LITNCVDKYSVERDN	KBTBD12	401	Q3ZCT8
ENCYQSILELEKERI	NOSTRIN	206	Q8IVI9
VFREVETLYQCQGNK	MKNK1	91	Q9BUB5
RCEVEIVLKANYIQV	MCM9	256	Q9NXL9
CFDSFEYVKTIRQQI	RASL10B	96	Q96S79
ICDVSRQELNKIYDA	RARS1	311	P54136
QECRQIDLVDNYFVK	TRIM33	186	Q9UPN9
LICNVSLEYEKTEVN	CCT6B	231	Q92526
QVIRVFKVDQQSCYI	RAPGEF6	751	Q8TEU7
LVKSLCQDVEYEVRS	PPP4R4	216	Q6NUP7
IDTVINYKDRCNVEK	SMARCA2	1391	P51531
KDIYQFLCNASEREV	TNFRSF21	431	O75509
KYRQLEAQELDVCRS	TDRD9	86	Q8NDG6
CRYNIVLKDREEVFL	LIPI	436	Q6XZB0
INDRTVNYVLKCREV	PLEKHG4	1061	Q58EX7
EEKDQICDFLYGRVQ	RECQL4	1046	O94761
VNEYTFLLEQCTVKI	SAMD9	1366	Q5K651
YKEECQRIFDLQNKV	TAF1L	1081	Q8IZX4
LTDILEQEQCFYRVR	TAF2	681	Q6P1X5
RLQCTYIEVEQVSKT	SCRN2	56	Q96FV2
NDNSEYVETIIAKCI	PSMD1	91	Q99460
DSCRRIQEAYEKIVA	AGMAT	136	Q9BSE5
LECYRLEETIQITQK	VPS8	1051	Q8N3P4
VYQCLSEERVKNKTV	SEMA4D	621	Q92854
EVFRSIVLNEYKRCD	PNPT1	346	Q8TCS8
VQRFEIAKYCSSDQV	PI4KAP2	46	A4QPH2
EKEFYVDQNVSIKCR	SVEP1	3371	Q4LDE5
CLAYRKEDRIDVQQL	TLK2	721	Q86UE8
QLAYCVVQFLEKDTT	PPP2R5A	291	Q15172
EREEEICIFYEKINI	CCDC146	646	Q8IYE0
EYVKCLENRVAVLEN	ATF1	236	P18846
KESCVVRVTVQYVQS	CLMP	216	Q9H6B4
YENILKCAFQEITVQ	CLBA1	146	Q96F83
LLVENIIDIYKQECS	TRIM63	96	Q969Q1
KQECLITTFQDVYFV	TPH1	361	P17752
CLKDYFEIQIRDGQV	RNF14	246	Q9UBS8
ERQVNEECYFKQVNV	ZNF565	166	Q8N9K5
KECVQQLAENTRYFR	SPTLC2	436	O15270
DVSRCVAERKYTQEQ	SMOC2	86	Q9H3U7
LACVERIEKYQDSFL	THRB	386	P10828
RLAECVKQVITKEYE	VPS45	186	Q9NRW7
RALKFQQYVQECADI	SPTA1	156	P02549
NCDYVIVSGAQRKEE	YJU2B	106	P13994
ICQQRNFVEETVYLL	VPS41	646	P49754
REQREKYELVAVCTV	RET	231	P07949
IDITQKYVAVACQDR	WDR62	636	O43379
GVEQEIYFKVCRDNS	TJP1	1666	Q07157
KQEVESFCYQIVSES	ZBED5	46	Q49AG3
YDCVREKIFLTLENV	ZBED6	461	P86452
SIREDILYVQVKFVC	ZSWIM3	46	Q96MP5
RVQQVELICEYNDLK	UBR7	366	Q8N806
RQKLNFSYCEETEIE	WEE2	11	P0C1S8
DFQYCEQAKSVIVRN	UBR2	276	Q8IWV8
EEAVYRNIQACKELA	CCT8	26	P50990
FDVKCVTNLELYQER	TCTN2	316	Q96GX1
YNVKSRECVEQLQLE	ZNF106	1601	Q9H2Y7
SLEEAEIYFKININC	TRPC4	51	Q9UBN4
EDYLRQVLCKAAESV	ATP6V0A2	281	Q9Y487
LQACTEAVIENKTRY	ZRANB3	351	Q5FWF4
YAFVKLKEQECRNIV	ATP6V0D1	316	P61421
TRFDQQCGELDVYKV	GUCY1A1	511	Q02108
AQLKYNIEVVCEYIV	EIF2S3	226	P41091
VAENNLCSQYEEKVR	MX1	36	P20591
VQYFNNKIICDLVEE	MYO1C	471	O00159
NCRLEVIIEESYDFK	SLC8A2	656	Q9UPR5
LCDKVQKDDIQIRFY	NFKB1	271	P19838